Liver function and muscle loss as predictors in cirrhosis with confusion
Part of Digestive system clinical trials.
This study looks at how two measures—liver function (ALBI score) and muscle loss (sarcopenia)—help predict outcomes in people with cirrhosis who have episodes of confusion or drowsiness (hepatic encephalopathy). If you qualify, researchers will track your health to see how these factors affect recovery and complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis (liver scarring) and hepatic encephalopathy (confusion or drowsiness from liver disease).
- You do not have acute liver failure (sudden severe liver damage).
- You have not had a previous portosystemic shunt surgery or a TIPS procedure.
- You have not had a liver or other organ transplant.
- You do not have end-stage kidney disease or liver cancer (HCC).
- You are not taking warfarin (blood thinner) for any reason.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with liver cirrhosis develop confusion after upper abdominal surgery. It uses advanced biological tests (called multi-omics) to find clues that might help prevent this confusion in the future.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
This study is creating a new test to measure thinking and memory problems in people with liver cirrhosis. It may help doctors find these problems earlier.
This study looks at the gut microbiome (the helpful bacteria in your gut) and muscle loss (sarcopenia) in people with liver cirrhosis. It may help researchers understand what changes in the gut and body can go along with getting weaker, so better treatments can be developed.
This trial tests whether a special nutrition plan can help treat muscle loss in people with liver cirrhosis who also have fluid buildup that doesn't improve with standard treatment. It aims to improve strength and outcomes after a procedure to place a shunt in the liver.
This study tests remote monitoring for people with liver cirrhosis. Instead of always coming to the clinic, you may use tools at home to track your health, which could make managing your condition easier.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.